secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001193125-23-209112
Event type: regulatory
Sentiment:  positive
Materiality: 0.40
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma regains Nasdaq minimum bid price compliance
-------------------------------------------------------------

- Received Nasdaq notice on Aug 9, 2023, confirming compliance with Bid Price Rule 5550(a)(2).
- Compliance achieved after closing price at $1.00/share or higher for 10 consecutive trading days.
- Original deficiency notice was received on Sep 6, 2022, for bid price below $1.00 for 30 days.
- Nasdaq has closed the matter; no further action required from the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523209112/0001193125-23-209112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523209112/d544334d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-209112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer